Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.77M Buy
5,398
+31
+0.6% +$9.83K 0.31% 71
2025
Q3
$1.51M Buy
5,367
+16
+0.3% +$4.64K 0.28% 77
2025
Q2
$1.55M Buy
5,351
+21
+0.4% +$5.95K 0.33% 66
2025
Q1
$1.64M Sell
5,330
-3,645
-41% -$1.08M 0.4% 48
2024
Q4
$2.34M Buy
8,975
+41
+0.5% +$12.2K 0.32% 57
2024
Q3
$2.88M Sell
8,934
-163
-2% -$53.3K 0.46% 46
2024
Q2
$2.83M Buy
9,097
+4,206
+86% +$1.24M 0.35% 57
2024
Q1
$1.38M Sell
4,891
-2,850
-37% -$834K 2.63% 7
2023
Q4
$2.23M Buy
7,741
+332
+4% +$90.5K 0.37% 55
2023
Q3
$1.99M Sell
7,409
-197
-3% -$49.2K 0.59% 31
2023
Q2
$1.71M Buy
+7,606
New +$1.76M 0.28% 72

Other funds holding AMGN

ORG Partners's AMGN Position: Q4 2025 in Review

ORG Partners increased its Amgen (AMGN) stake by 0.58% in Q4 2025, buying an estimated $9.83K and bringing the position to 5,398 shares worth $1.77M. The position accounts for 0.31% of the portfolio, ranked #71.

ORG Partners first reported a position in AMGN in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.88M in Q3 2024. 3,093 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • ORG Partners held 5,398 shares of Amgen worth $1.77M as of Q4 2025.
  • ORG Partners bought 31 Amgen shares in Q4 2025, an estimated $9.83K.
  • Amgen made up 0.31% of ORG Partners's portfolio in Q4 2025, its #71 holding.
  • ORG Partners first reported a position in Amgen in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Amgen position peaked at $2.88M in Q3 2024.
  • 3,093 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.